Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 25th March 2026
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

FIVP ‘disappointed’ in CMA’s medicines approach
FIVP chair Rita Dingwall warns remedy could be 'devastating' for independent practices.

CMA proceeds with controversial pharmacy remedy.

The Federation of Independent Veterinary Practices (FIVP) has expressed its disappointment in some remedies published by the Competition and Markets Authority (CMA).

The report, published 26 March 2026, revealed that the CMA would be proceeding with controversial remedies that could see independent practices direct clients to online pharmacies.

As part of the remedy package, all veterinary practices will be required to advise pet owners that their pet’s medication ‘may be cheaper if bought elsewhere’. Vets will also be told to issue prescriptions by the end of consultation (hard copy) or within 48 hours (digital copy).

FIVP suggests that this remedy could have a ‘devastating’ for independent practices. It states that, with large veterinary groups owning the major online pharmacies, this strategy could lead to ‘the monopolisation of veterinary medicines’.

Calling on data from its Impact Assessment survey, which surveyed independent practices across country, the organisation says that 94 per cent of respondents did not support such remedies.

FIVP says that, if independent practices lose revenue from medicine sales, they will be unable to subsidise the costs of services and procedures. This could mean practices are forced to increase their prices to keep their business viable.

The organisation has also expressed concern about a proposed comparison site, through which clients will be able to directly compare practices on an RCVS website. It warns that this remedy could lead to so-called ‘practice-hopping’ for the cheapest price, which could be ‘detrimental’ to continuity of care.

Rita Dingwall, chair of FIVP, said: “We are fully supportive of measures that increase transparency and our members work tirelessly to provide a great service at an affordable cost.

“Over 90 per cent of independent vets agree that a move to online pharmacies will impact their ability to provide veterinary services to pets in need. We encourage pet owners to support their local independent vet and not online pharmacies, many of which are owned by corporates.

“We are supportive of a new, modern Veterinary Surgeons Act, but this is a separate matter from the CMA review.”

FIVP's full response can be read here.

Image © FIVP

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.